Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00058552
Status:
COMPLETED
Last Update Posted:
2017-03-08
First Post:
2003-04-08
Brief Title:
A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 Pertuzumab in Subjects With Advanced Ovarian Cancer
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| Advanced refractory or recurrent ovarian cancer | View |